$INFU
InfuSystem Holdings, Inc

2015 Q4 Form 10-Q Financial Statement

#000119312515374671 Filed on November 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $18.74M $18.31M $16.61M
YoY Change 15.25% 10.22% 5.55%
Cost Of Revenue $4.950M $3.580M $3.221M
YoY Change 22.52% 11.15% 17.13%
Gross Profit $13.79M $12.88M $11.73M
YoY Change 12.85% 9.78% 3.44%
Gross Profit Margin 73.59% 70.32% 70.61%
Selling, General & Admin $9.620M $8.338M $7.399M
YoY Change 18.62% 12.69% 6.09%
% of Gross Profit 69.76% 64.75% 63.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.240M $100.0K $100.0K
YoY Change 1013.51% 0.0% 0.0%
% of Gross Profit 59.75% 0.78% 0.85%
Operating Expenses $10.70M $10.55M $9.287M
YoY Change 20.77% 13.57% -1.38%
Operating Profit $3.090M $2.330M $2.443M
YoY Change -8.04% -4.63% 27.04%
Interest Expense -$310.0K $338.0K $752.0K
YoY Change -60.26% -55.05% -10.26%
% of Operating Profit -10.03% 14.51% 30.78%
Other Income/Expense, Net $40.00K -$385.0K -$749.0K
YoY Change -500.0% -48.6% -11.36%
Pretax Income $2.220M $1.945M $1.694M
YoY Change 12.12% 14.82% 57.14%
Income Tax $700.0K $807.0K $842.0K
% Of Pretax Income 31.53% 41.49% 49.7%
Net Earnings $1.530M $1.138M $852.0K
YoY Change 47.12% 33.57% 31.28%
Net Earnings / Revenue 8.16% 6.21% 5.13%
Basic Earnings Per Share $0.05 $0.04
Diluted Earnings Per Share $66.35K $0.05 $0.04
COMMON SHARES
Basic Shares Outstanding 22.51M shares 22.45M shares 22.20M shares
Diluted Shares Outstanding 22.84M shares 22.51M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $800.0K $1.000M $1.900M
YoY Change 60.0% -47.37% 111.11%
Cash & Equivalents $818.0K $989.0K $1.902M
Short-Term Investments
Other Short-Term Assets $861.0K $824.0K $621.0K
YoY Change 36.02% 32.69% -0.64%
Inventory $1.916M $1.907M $1.589M
Prepaid Expenses
Receivables $12.62M $12.80M $11.51M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.96M $18.77M $17.91M
YoY Change 22.65% 4.77% 26.57%
LONG-TERM ASSETS
Property, Plant & Equipment $2.370M $2.321M $2.370M
YoY Change -3.3% -2.07% 191.51%
Goodwill $1.000M
YoY Change
Intangibles $31.53M $30.73M $24.46M
YoY Change 25.77% 25.61% 1.6%
Long-Term Investments
YoY Change
Other Assets $251.0K $225.0K $208.0K
YoY Change 18.4% 8.17% 13.04%
Total Long-Term Assets $76.40M $74.53M $63.11M
YoY Change 17.98% 18.1% 1.4%
TOTAL ASSETS
Total Short-Term Assets $18.96M $18.77M $17.91M
Total Long-Term Assets $76.40M $74.53M $63.11M
Total Assets $95.36M $93.30M $81.02M
YoY Change 18.88% 15.15% 6.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.586M $5.526M $4.570M
YoY Change 26.29% 20.92% 5.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.842M $5.266M $4.238M
YoY Change -71.45% 24.26% 30.84%
Total Short-Term Liabilities $15.26M $14.81M $12.11M
YoY Change 3.58% 22.29% 16.54%
LONG-TERM LIABILITIES
Long-Term Debt $26.55M $29.97M $23.63M
YoY Change 39.49% 26.82% -3.07%
Other Long-Term Liabilities $3.000M
YoY Change
Total Long-Term Liabilities $29.78M $29.97M $23.63M
YoY Change 56.48% 26.82% -3.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.26M $14.81M $12.11M
Total Long-Term Liabilities $29.78M $29.97M $23.63M
Total Liabilities $45.04M $44.78M $35.74M
YoY Change 33.4% 25.28% 2.79%
SHAREHOLDERS EQUITY
Retained Earnings -$40.92M -$42.45M -$44.74M
YoY Change -6.37% -5.13% -6.65%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.32M $48.52M $45.28M
YoY Change
Total Liabilities & Shareholders Equity $95.36M $93.30M $81.02M
YoY Change 18.88% 15.15% 6.06%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $1.530M $1.138M $852.0K
YoY Change 47.12% 33.57% 31.28%
Depreciation, Depletion And Amortization $8.240M $100.0K $100.0K
YoY Change 1013.51% 0.0% 0.0%
Cash From Operating Activities $1.660M $1.600M $2.390M
YoY Change -45.75% -33.05% -5.91%
INVESTING ACTIVITIES
Capital Expenditures -$860.0K $80.00K -$2.650M
YoY Change -66.14% -103.02% 215.48%
Acquisitions
YoY Change
Other Investing Activities $1.640M -$1.390M $1.180M
YoY Change -2.38% -217.8% 9.26%
Cash From Investing Activities $780.0K -$1.310M -$1.460M
YoY Change -190.7% -10.27% -684.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.620M -90.00K -90.00K
YoY Change -26.61% 0.0% -95.45%
NET CHANGE
Cash From Operating Activities 1.660M 1.600M 2.390M
Cash From Investing Activities 780.0K -1.310M -1.460M
Cash From Financing Activities -2.620M -90.00K -90.00K
Net Change In Cash -180.0K 200.0K 840.0K
YoY Change -86.86% -76.19% 3.7%
FREE CASH FLOW
Cash From Operating Activities $1.660M $1.600M $2.390M
Capital Expenditures -$860.0K $80.00K -$2.650M
Free Cash Flow $2.520M $1.520M $5.040M
YoY Change -55.0% -69.84% 49.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22514484 shares
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1902000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22467409 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22665069 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6249000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
48998000
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29969000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
700000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6168000
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90964000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5231000
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
35235000
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4018000
CY2015Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5266000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5526000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4938000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41968000
CY2015Q3 us-gaap Liabilities
Liabilities
44779000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93777000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4996000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14810000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
225000
CY2015Q3 us-gaap Assets
Assets
93777000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4969000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4504000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30726000
CY2015Q3 us-gaap Inventory Net
InventoryNet
1907000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13584000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1004000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2321000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
9274000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2396000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
19556000
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
824000
CY2015Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
142000
CY2015Q3 us-gaap Goodwill
Goodwill
1000000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
989000
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12944000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6579000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2015Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
49692000
CY2015Q3 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
170000
CY2015Q3 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
18966000
CY2015Q3 infu Medical Equipment Net
MedicalEquipmentNet
26863000
CY2015Q3 infu Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
11891000
CY2015Q3 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2032000
CY2015Q3 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
25019000
CY2015Q3 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
24831000
CY2015Q3 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
50020000
CY2015Q3 infu Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSale
1800000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22308730 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22506421 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
46452000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19032000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90155000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
25484000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3062000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6452000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5215000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4739000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43705000
CY2014Q4 us-gaap Liabilities
Liabilities
33761000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80213000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14729000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
212000
CY2014Q4 us-gaap Assets
Assets
80213000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25073000
CY2014Q4 us-gaap Inventory Net
InventoryNet
1758000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10300000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2451000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
15458000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
633000
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1194000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13756000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
42012000
CY2014Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
121000
CY2014Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
16939000
CY2014Q4 infu Medical Equipment Net
MedicalEquipmentNet
22069000
CY2014Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2255000
CY2014Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23311000
CY2014Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
19814000
CY2014Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
43246000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4204000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22364999 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
256856 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22108143 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.451 pure
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
49101000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7168000
us-gaap Net Income Loss
NetIncomeLoss
2321000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
2756000
us-gaap Sales Revenue Net
SalesRevenueNet
50227000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
44150000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
178000
us-gaap Operating Income Loss
OperatingIncomeLoss
6557000
us-gaap Gross Profit
GrossProfit
35729000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2329000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4228000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6077000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
52876000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1907000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9024000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7762000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
47814000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
764000
us-gaap Operating Expenses
OperatingExpenses
29172000
us-gaap Interest Expense
InterestExpense
2355000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1975000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1465000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5193000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14723000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1876000
us-gaap Depreciation
Depreciation
200000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4811000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
5474000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
2400000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5385000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-03-23
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22769715 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
389513 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22380202 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Trading Symbol
TradingSymbol
INFU
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.412 pure
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
52681000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9390000
us-gaap Net Income Loss
NetIncomeLoss
1737000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1950000
us-gaap Sales Revenue Net
SalesRevenueNet
52587000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
47604000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
144000
us-gaap Operating Income Loss
OperatingIncomeLoss
5580000
us-gaap Gross Profit
GrossProfit
37201000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3024000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
5899000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1599000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
157000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2556000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4983000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
53910000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
819000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10251000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8079000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
60605000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
474000
us-gaap Operating Expenses
OperatingExpenses
31621000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
156000
us-gaap Interest Expense
InterestExpense
1397000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12690000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7779000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2599000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17652000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Depreciation
Depreciation
300000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3790000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
5135000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3400000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22511159 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
308106 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22203053 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
852000
CY2014Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
998000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
16613000
CY2014Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14505000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2443000
CY2014Q3 us-gaap Gross Profit
GrossProfit
11730000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-749000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1694000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2108000
CY2014Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
17499000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
842000
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3221000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2483000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
9287000
CY2014Q3 us-gaap Interest Expense
InterestExpense
752000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4916000
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
622000
CY2014Q3 us-gaap Depreciation
Depreciation
100000
CY2014Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1266000
CY2014Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1662000
CY2014Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
900000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22838371 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
389522 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22448849 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
1369000
CY2015Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1369000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
18692000
CY2015Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
16849000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2711000
CY2015Q3 us-gaap Gross Profit
GrossProfit
13258000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-385000
CY2015Q3 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
100000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2326000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1843000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2655000
CY2015Q3 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
200000
CY2015Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
18692000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
957000
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3580000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
10547000
CY2015Q3 us-gaap Interest Expense
InterestExpense
338000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5683000
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
756000
CY2015Q3 us-gaap Depreciation
Depreciation
100000
CY2015Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1453000
CY2015Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1854000
CY2015Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1300000

Files In Submission

Name View Source Status
0001193125-15-374671-index-headers.html Edgar Link pending
0001193125-15-374671-index.html Edgar Link pending
0001193125-15-374671.txt Edgar Link pending
0001193125-15-374671-xbrl.zip Edgar Link pending
d32196d10q.htm Edgar Link pending
d32196dex311.htm Edgar Link pending
d32196dex312.htm Edgar Link pending
d32196dex321.htm Edgar Link pending
d32196dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g32196g52n02.jpg Edgar Link pending
infu-20150930.xml Edgar Link completed
infu-20150930.xsd Edgar Link pending
infu-20150930_cal.xml Edgar Link unprocessable
infu-20150930_def.xml Edgar Link unprocessable
infu-20150930_lab.xml Edgar Link unprocessable
infu-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending